Medtech Hot Takes of the Month of February

These were among the most thought-provoking quotes we heard from medical device and diagnostics thought leaders in February.

Foldax’s Presentation at CRT Could Lead to a More In-Depth Trial

The Salt Lake City, UT-based company is one-step closer to moving toward first-in-human trials for its Tria TAVR valve.

Long-Term Data for Biotronik’s Orsiro DES Holds Up

The company presented the data at the Cardiovascular Research Technologies annual conference.

Is ZimVie Going to Be the Breakout Medtech Company of 2022?

Medtech veteran, Vafa Jamali joins us for an episode of Let's Talk Medtech in one of his first interviews since being announced as CEO of ZimVie.

Wearable Offers a Simple Path for Fluorescence-Guided Surgeries

Called the first wearable fluorescence guided surgery system, Reveal offers surgeons the chance to move freely and change perspective simply by changing their line of sight.

HeartFlow Moves Past Canceled SPAC and Appoints CEO

The Redwood City, CA-based company said it has appointed John Farquhar as its president and CEO.

FDA Warns Against More Unauthorized COVID Tests

Unauthorized COVID-19 tests continue to plague the regulatory agency. FDA flagged three such tests on Tuesday.

iTotal CR Knee Replacement System from Conformis Earns Updated Rating from UK Panel

The jump from a 5A rating to a 7A rating is based on seven years of implant performance data.

Ascensia Eyes Market in Europe for CGM App

The Parsippany, NJ-based company has launched the Eversense NOW Remote Monitoring App for the Android Operating System.

‘The Dropout’: Binge Worthy or Don’t Bother?

Starring Amanda Seyfried as Elizabeth Holmes, “The Dropout” is Hulu’s limited series about the unbelievable rise and fall of Theranos.

Dexcom Wants to Take its CGM Technology to the Hospital Setting

The San Diego, CA-based company won breakthrough device designation for its CGMs to be used in the hospital setting.